Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation

AIMS: The safety and efficacy, particularly, the factors associated with the renal prognosis, were assessed over 12 months after the initiation of luseogliflozin therapy in Japanese patients with type 2 diabetes and renal impairment. METHODS: In total, 238 patients treated with luseogliflozin (2.5 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Hiroyuki, Matsumoto, Suzuko, Izutsu, Takuma, Kusano, Eiji, Kondo, Jiro, Inoue, Hideyuki, Antoku, Shinichi, Yamasaki, Tomoko, Mori, Toshiko, Togane, Michiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959360/
https://www.ncbi.nlm.nih.gov/pubmed/33720983
http://dx.doi.org/10.1371/journal.pone.0248577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959360/
https://www.ncbi.nlm.nih.gov/pubmed/33720983
http://dx.doi.org/10.1371/journal.pone.0248577

Ejemplares similares